Optical Genome Mapping Market Report 2026

Optical Genome Mapping Market Overview

• Optical Genome Mapping market size has reached to $0.23 billion in 2025 • Expected to grow to $0.74 billion in 2030 at a compound annual growth rate (CAGR) of 25.9% • Growth Driver: Precision Medicine Driving Growth In The Optical Genome Mapping Market • Market Trend: Adoption of OGM-Based Laboratory Tests for Comprehensive Structural Variant Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Optical Genome Mapping Market?

Optical genome mapping (OGM) is a cutting-edge genomic analysis technique that involves creating high-resolution, large-scale maps of Deoxyribonucleic Acid (DNA) molecules to identify structural variations and genome architecture. This technology leverages optical methods to visualize and analyze long strands of DNA, allowing for the detection of large-scale structural variations such as insertions, deletions, duplications, inversions, and translocations, which are often difficult to identify with traditional sequencing methods. The main products of optical genome mapping are instruments, consumables and reagents, software, and services. Instruments in the optical genome mapping market include the hardware and machinery used to visualize and analyze large DNA molecules. It is used for various applications including structural variant detection, genome assembly, microbial strain typing, and others by biotechnology and pharmaceutical companies, clinical laboratories, academic research institutes, and others.

What Is The Optical Genome Mapping Market Growth Forecast?

The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.74 billion in 2030 at a compound annual growth rate (CAGR) of 25.9%. The growth in the forecast period can be attributed to increasing integration of ogm in clinical laboratories, rising investment in precision medicine initiatives, growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, declining costs of genomic analysis technologies. Major trends in the forecast period include growing adoption of optical genome mapping in structural variant detection, increasing use of ogm in rare disease and cancer research, rising demand for high-resolution long-read genomic analysis, expansion of ogm applications in clinical diagnostics, growing preference for complementary use of ogm with sequencing technologies.

Global Optical Genome Mapping Market Segmentation

1) By Product: Instruments, Consumables And Reagents, Software, Services 2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications 3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users Subsegments: 1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices 2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells 3) By Software: Data Analysis Software, Image Processing Software, Mapping Software 4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Is The Driver Of The Optical Genome Mapping Market?

The increasing demand for precision medicine is expected to propel the growth of the optical genome mapping market going forward. Precision medicine is an approach to healthcare that customizes medical treatment and prevention strategies to individual characteristics such as genetic makeup, lifestyle, and environment. Precision medicine demand is driven by the rising prevalence of chronic diseases, advancements in genomic technologies, increasing investment and funding, and patient demand for personalized care. optical genome mapping enhances the capabilities of precision medicine by providing a detailed and accurate understanding of the genomic alterations associated with various diseases. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing demand for precision medicine is driving the growth of the optical genome mapping industry.

Key Players In The Global Optical Genome Mapping Market

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Global Optical Genome Mapping Market Trends and Insights

Major companies are operating the optical genome mapping (OGM) market focusing on developing technological advancements such as OGM-based laboratory-developed tests (LDTs) for genome-wide structural variant detection to enhance diagnostic accuracy, improve workflow efficiency, and reduce reliance on multiple traditional cytogenetic tests. An OGM-based LDT uses ultra-long, high-molecular-weight DNA molecules that are fluorescently labeled and linearized in nanochannels, allowing high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions across the genome capabilities that are often missed by short-read sequencing or microarrays. For instance, in March 2023, Bionano Laboratories, a U.S.-based CLIA-certified subsidiary of Bionano Genomics, launched the OGM Dx Postnatal Whole Genome SV test. The product enables genome-wide detection of structural variants in patients with developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or undiagnosed genetic conditions. It integrates high-resolution OGM with variant calling in a single-test workflow, reducing the need for multiple classical cytogenetic assays and providing faster, more comprehensive diagnostic insights.

What Are Latest Mergers And Acquisitions In The Optical Genome Mapping Market?

In June 2024, Bionano Genomics, a U.S.-based provider of optical genome mapping (OGM) systems, consumables, and software, partnered with Revvity, to integrate Bionano’s VIA™ software into Revvity’s newborn sequencing research workflow. Through this collaboration, the companies aim to leverage OGM data alongside next-generation sequencing (NGS) workflows to enhance comprehensive variant analysis and improve structural variant detection. This partnership highlights the optical genome mapping market’s growing focus on software-enabled integration with broader genomics research platforms. Revvity, a U.S.-based provider of genomics research solutions..

Regional Outlook

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Optical Genome Mapping Market?

The optical genome mapping market includes revenues earned by entities by providing services such as structural variation detection, genome assembly, microbial strain typing, clinical diagnostics, cancer genomics bioinformatics, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The optical genome mapping market also includes sales of instruments, consumables and reagents, software, and bioinformatics tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Optical Genome Mapping Market Report 2026?

The optical genome mapping market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the optical genome mapping industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.